Farms.com Home   News

U.S. Meat And Poultry Industry Represents $1.02 Trillion In Total Economic Output, Study Shows

The U.S. meat and poultry industry accounts for $1.02 trillion in total economic output, or 5.6 percent of gross domestic product (GDP), according a new economic impact analysis conducted by John Dunham and Associates for the Meat Institute.
 
The meat and poultry industry is responsible for 5.4 million jobs and $257 billion in wages, the report found. An estimated 527,019 people work in production and packing, importing operations, sales, packaging and direct distribution of meat and poultry products. Wholesaling directly employs an estimated 232,418 individuals in all 50 states, and 1.11 million employees’ retail jobs depend on the sale of meat and poultry products to the public. All totaled, the meat and poultry industry (packers, processors, wholesalers and retailers) directly employs 1.9 million people, paying $71.63 billion in wages and benefits.
 
The report also found that approximately two million full-time equivalent jobs are created in firms that supply goods and services to the meat and poultry industry, including in industries as broad as real estate services, trucking and container manufacturing. An additional 1.57 million jobs depend on the re-spending of wages by meat, poultry and supplier industry employees.
 
Furthermore, the analysis calculates the industry’s contribution to the public finances of communities. Traditional direct taxes paid by meat and poultry industry firms and their employees provide more than $108.42 billion in revenue to the federal, state and local governments. Meanwhile, meat and poultry consumption generates $3.26 billion in state sales taxes.
Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.